South Korean Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

5 companies

AprilBioLtd

Market Cap: ₩1.3t

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

A397030

₩54,900.00

15.6%

238.9%

Aimed Bio

Market Cap: ₩3.7t

Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.

A0009K0

₩57,600.00

-7.4%

n/a

3billion

Market Cap: ₩579.0b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

A394800

₩18,230.00

6.5%

256.1%

Seegene

Market Cap: ₩1.1t

Manufactures and sells molecular diagnostics products worldwide.

A096530

₩23,800.00

-3.1%

4.4%

ABL Bio

Market Cap: ₩11.0t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

A298380

₩200,000.00

6.7%

568.9%